Arnar Rafnsson

Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus

Alexey Shemyakin, Oskar Kövamees, Arnar Rafnsson et al. · Circulation · 2012 · 183 citations

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

Arnar Rafnsson, Felix Böhm, Magnus Settergren et al. · Diabetologia · 2011 · 74 citations · Full text

Medicine, Randomised Trial, Diabetes +7

Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes

Christian Jung, Arnar Rafnsson, Alexey Shemyakin et al. · International Journal of Cardiology · 2009 · 57 citations

Endothelial Cell Pathobiology, Metabolic Syndrome, Endothelial Progenitor Cells +14

Endothelin-1 increases expression and activity of arginase 2 via ETB receptors and is co-expressed with arginase 2 in human atherosclerotic plaques

Arnar Rafnsson, Ljubica Matic, Mariette Lengquist et al. · Atherosclerosis · 2019 · 34 citations

Inflammation, Vascular Disease, Etb Receptors +9

Selective endothelin ETA and dual ETA/ETB receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease

Arnar Rafnsson, Alexey Shemyakin, John Pernow · Life Sciences · 2014 · 22 citations · Full text